Neurointerventional Surgery Made Simple: Union Strong's UAlpha™ Empowers Neurointerventionalists

Cerebrovascular vessels are among the most complex in the human body. The learning journey for neurointerventionalists is arduous, requiring not only familiarity with the course and distribution of every cerebral vessel but also the ability to visualize their three-dimensional architecture, as well as mastery of neurointerventional techniques. Progressing from a novice to a proficient operator entails a considerably long learning curve.

Union Strong^®To address this critical pain point in clinical learning, relentless exploration has led to the development of the UAlpha™ Intelligent Intracranial Vascular Simulation System, “purpose-built for intracranial vascular simulation.” This product encompassesUAlpha™ Model 3D Whole-Brain Vascular Model, UAlpha™Simu Local Cerebrovascular Model, and UAlpha™Opera Intracranial Vascular Surgery Simulation System,The product is precisely 3D-printed at a 1:1 scale to accurately replicate the intricate structures of cerebral blood vessels. Crafted from advanced materials, it features lesion-specific vascular segments suitable for interventional procedures, offering a highly realistic tactile experience and simulating the dynamic internal environment of the brain. It supports a wide range of scenarios, including outpatient consultations, teaching demonstrations, review of classic cases, medical device testing, coil embolization, and thrombectomy. This significantly shortens the learning curve for physicians, facilitates the training of neurointerventional specialists in China, and ultimately helps serve patients across diverse regions.

UAlpha™ Model 3D Whole-Cerebrovascular ModelUnion Strong^®China’s first 1:1 life-size vascular model of the human brain, specifically designed for learning and demonstration of intracranial vasculature. Manufactured using high-precision 3D printing technology, this product accurately visualizes perforating vessels smaller than 1 mm in diameter. Crafted from specialized materials, it offers exceptional long-lasting luster and enables 360° panoramic viewing, making it suitable for diverse applications including outpatient consultations, teaching demonstrations, and public health education.

UAlpha™Simu Local Cerebrovascular ModelFabricated using ultra-high-precision printing technology, this model meticulously reconstructs the three-dimensional spatial architecture of blood vessels, accurately depicting microvascular structures smaller than 1 mm. Crafted from advanced materials, it simulates the physiological environment of blood vessels, restoring their true elasticity and providing a realistic tactile experience for surgical maneuvers. The product features a high-transparency cylindrical design that offers an enlarged field of view, clearly revealing vascular anatomy. It is suitable for various applications, including educational demonstrations, simulation-based review of classic cases, and testing of consumable medical products.

UAlpha™Simu supports customization. Upon receipt of qualified imaging data, the model will be dispatched within 48 hours to ensure the fastest possible delivery to you!

UAlpha™ Opera Intracranial Interventional Surgery Simulation SystemDesigned specifically for surgical simulation, this system employs a black-box simulation approach to replicate the interventional surgery environment. It features a fully realistic DSA surgical screen perspective and includes multiple color presentation modes to meet the needs of various scenarios. The system utilizes a biomimetic human brain ecological environment with continuous dynamic fluid flow to simulate dynamic blood circulation. Crafted from high-tech materials, it precisely restores vascular elasticity and softness, providing an authentic tactile experience of blood vessels during surgery. With comprehensive scenario coverage, it supports the simulation of multiple surgical procedures, including aneurysm embolization and thrombectomy simulations.

UAlpha™ has obtained product patents, and these products are at Union Strong^®It has played a significant role in previous scientific research efforts and collaborative projects under the 13th Five-Year Plan. During practical application, we have found that UAlpha™ is adaptable to a wide range of scenarios, meeting the needs of R&D, teaching, and surgical simulation, among others. We hope that the launch of UAlpha™ will promote advancements in the field of neurointervention and help expand and strengthen the community of neurointerventional physicians.

Union Strong

Union Strong^®

Union Strong (Beijing) Tech. Co. Ltd, established in September 2016, is China’s first high-tech company to address the critical pain points in the treatment of cerebrovascular diseases. After years of R&D accumulation, the U-series^®The product series comprehensively covers intelligent diagnosis and treatment services across the entire lifecycle of cerebrovascular disease—from prevention, screening, and diagnosis to treatment, rehabilitation, and follow-up—leading the vertical sector of intelligent cerebrovascular care in China.

Guided by its mission to “empower healthcare with AI and safeguard lives through technology,” the company leverages algorithms to drive product innovation and maintains close collaborations with several national centers for neurological diseases as well as numerous provincial and municipal Grade 3A hospitals. It enhances precision and intelligence in imaging and clinical diagnosis, while improving surgical accuracy, reducing operative time, and boosting therapeutic efficacy and safety during treatment. Additionally, it significantly shortens the learning curve for junior physicians. Extending its services beyond the hospital to pre- and post-diagnosis scenarios, the company is building a comprehensive service system for prevention, screening, rehabilitation, and follow-up care targeting 700 million healthy adults and tens of millions of cerebrovascular disease patients. With steadfast commitment, it strives toward its vision of becoming a “globally leading intelligent diagnosis and treatment platform for stroke.”